Digital Podcast
Saving Minds show

Saving Minds

Summary: Dr. Elliot Goldstein and Shanti Skiffington discuss the future of medicine for Alzheimer’s and Parkinson’s diseases with the world's leading researchers.

Join Now to Subscribe to this Podcast

Podcasts:

 Episode 10 – AAIC 2019 Recap with Dr. Johanne Kaplan | File Type: audio/mp4 | Duration: 13:23

This week Shanti and Dr. Johanne Kaplan recap AAIC 2019 and discuss the exciting data that came out of the conference. For more information check out https://promisneurosciences.com/

 Episode 9 – AAIC 2019 Preview with Dr. Johanne Kaplan | File Type: audio/mp4 | Duration: 08:42

This week Shanti and Johanne preview AAIC and discuss what the hot topics at the conference are expected to be. 

 Episode 8 – 2019 Keystone Symposia Breakdown with Dr. Johanne Kaplan | File Type: audio/mp4 | Duration: 19:20

This week Shanti discusses some of the most exciting news coming out of the recent 2019 Keystone Symposia with Dr. Johanne Kaplan.

 Episode 7 – Dr. Johanne Kaplan on the Importance of Selectivity | File Type: audio/mp4 | Duration: 24:00

Shanti is joined by Dr. Johanne Kaplan, the Chief Development Officer at ProMIS Neurosciences. The two discuss Dr. Kaplan's career, and the current challenges researchers must tackle as they continue their search for a way to stop Alzheimer's disease. The two also discuss Dr. Kaplan's recent paper on the importance of selectivity in drug development for Alzheimer's.

 Episode 6 – The "One-Two Punch" of Abeta and Tau | File Type: audio/mp4 | Duration: 13:54

This week Dr. Goldstein and Shanti discuss the importance of the Tau protein in mediating the progression of Alzheimer's disease. They also discuss how drug makers can potentially target Tau when creating medication to stop or slow the spread of the disease.

 Episode 5 – Major Late-stage Alzheimer's Failures | File Type: audio/mp4 | Duration: 15:09

Dr. Goldstein and Shanti breakdown the news of the week. This week they discuss two major late-stage failures for promising Alzheimer's drugs, a new syndrome that is similar to Alzheimer's, and some important biomarker developments. 

 Episode 4 – How do Biomarkers Work? | File Type: audio/mp4 | Duration: 13:19

This is part two of our exploration of biomarkers. Elliot and Shanti discuss how biomarkers work and how they will play a critical role in the future of drug development for the various brain-wasting diseases.

 Episode 3 – Why Biomarkers Matter | File Type: audio/mp4 | Duration: 13:17

Dr. Goldstein and Shanti discuss why biomarkers are becoming increasingly important in the medical community. They also discuss how biomarkers are uniquely important in the quest for a cure for Alzheimer's.

 Episode 2 – Understanding Parkinson's Disease | File Type: audio/mp4 | Duration: 15:12

This week Dr. Goldstein and Shanti discuss Parkinson's disease. They discuss the underlying cause of Parkinson's, treatment options, side effects and the connection between Parkinson's and Alzheimer's

 Episode 1 – The Alzheimer's Public Health Crisis | File Type: audio/mp4 | Duration: 14:11

This week our hosts Dr. Elliot Goldstein MD and Shanti Skiffington provide a summary of the current efforts to find a cure for Alzheimer's disease.

Comments

Login or signup comment.